Clinical evaluation of the use of exemestane as further hormonal therapy after nonsteroidal aromatase inhibitors in postmenopausal metastatic breast cancer patients.

Source:http://linkedlifedata.com/resource/pubmed/id/17453821

Download in:

View as

General Info

PMID
17453821